Spero Therapeutics, Inc. (SPRO)
1.21
-0.01
(-0.82%)
USD |
NASDAQ |
Aug 24, 16:00
1.21
0.00 (0.00%)
After-Hours: 20:00
Spero Therapeutics Price : 1.21 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 1.22 | 1.246 | 1.21 | 1.22 | 359141.0 |
| Aug 20, 2026 | 1.22 | 1.27 | 1.20 | 1.21 | 558771.0 |
| Aug 19, 2026 | 1.20 | 1.24 | 1.192 | 1.23 | 480182.0 |
| Aug 18, 2026 | 1.20 | 1.20 | 1.175 | 1.20 | 477408.0 |
| Aug 17, 2026 | 1.21 | 1.24 | 1.19 | 1.19 | 299013.0 |
| Aug 14, 2026 | 1.26 | 1.26 | 1.194 | 1.23 | 744546.0 |
| Aug 13, 2026 | 1.26 | 1.30 | 1.21 | 1.24 | 1.293M |
| Aug 12, 2026 | 1.24 | 1.245 | 1.185 | 1.19 | 774554.0 |
| Aug 11, 2026 | 1.24 | 1.25 | 1.21 | 1.23 | 364060.0 |
| Aug 10, 2026 | 1.25 | 1.276 | 1.225 | 1.23 | 351020.0 |
| Aug 07, 2026 | 1.27 | 1.280 | 1.24 | 1.26 | 459026.0 |
| Aug 06, 2026 | 1.26 | 1.275 | 1.23 | 1.27 | 974682.0 |
| Aug 05, 2026 | 1.25 | 1.28 | 1.21 | 1.26 | 574908.0 |
| Aug 04, 2026 | 1.15 | 1.25 | 1.15 | 1.23 | 752105.0 |
| Aug 03, 2026 | 1.19 | 1.22 | 1.125 | 1.15 | 1.373M |
| Jul 31, 2026 | 1.20 | 1.214 | 1.17 | 1.17 | 824576.0 |
| Jul 30, 2026 | 1.20 | 1.22 | 1.175 | 1.20 | 487671.0 |
| Jul 29, 2026 | 1.20 | 1.21 | 1.16 | 1.19 | 1.056M |
| Jul 28, 2026 | 1.18 | 1.28 | 1.15 | 1.195 | 1.602M |
| Jul 27, 2026 | 1.20 | 1.230 | 1.16 | 1.18 | 1.347M |
| Jul 24, 2026 | 1.14 | 1.23 | 1.08 | 1.19 | 11.77M |
| Jul 23, 2026 | 1.28 | 1.28 | 1.10 | 1.16 | 3.733M |
| Jul 22, 2026 | 1.38 | 1.41 | 1.25 | 1.27 | 1.990M |
| Jul 21, 2026 | 1.43 | 1.44 | 1.37 | 1.38 | 2.182M |
| Jul 20, 2026 | 1.57 | 1.57 | 1.41 | 1.44 | 1.719M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Inovio Pharmaceuticals, Inc. | 1.25 |
| Fortress Biotech, Inc. | 2.93 |
| Kura Oncology, Inc. | 12.40 |
| Legend Biotech Corp. | 20.95 |
| ACADIA Pharmaceuticals, Inc. | 29.63 |
Price Related Metrics
| PE Ratio | 11.09 |
| PS Ratio | 1.626 |
| Price to Book Value | 1.592 |
| Price to Free Cash Flow | 3.567 |
| Earnings Yield | 9.02% |
| Market Cap | 70.36M |
| Operating PE Ratio | 27.08 |
| Normalized PE Ratio | 10.39 |